FDA approves Versa HD Radiation Therapy System (Elekta)

Elekta has received 510(k) clearance from the FDA for the Versa HD radiation therapy system for cancer treatment. Versa HD is an advanced linear accelerator system designed to improve patient care and treat a broader spectrum of cancers. The system is fully integrated with the Agility 160-leaf multileaf collimator (MLC), giving the Versa HD high-definition, high-speed beam shaping over a 40 X 40 cm field. This combination of fast MLC leaf speed with the new High Dose Rate mode allows clinicians to exploit high dose rate delivery - three times faster than previous generation Elekta linear accelerators. The system's high targeting accuracy is available over a large field-of-view, permitting delivery of high-definition (HD) beams to a wide spectrum of complex targets.